Related Experiment Video
Updated: Jul 4, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Mycobacterium avium complex-associated peritonitis in a patient on continuous ambulatory peritoneal dialysis
E L Falcone1, A Alam, N Tangri
1Faculty of Medicine, McGill University, Montreal, QC, Canada.
Abstract:
Continuous ambulatory peritoneal dialysis (CAPD)-associated peritonitis remains a major cause of morbidity in the dialysis population. Typically, infection is caused by gram positive bacteria and treated with empiric antibiotics. A subset of patients, however, develop culture negative peritonitis and may be infected with fungal or mycobacterial organisms. We present a case of Mycobacterium avium complex-associated peritonitis in a HIV negative patient on CAPD. Our patient suffered from technique failure and died from unrelated causes before treatment could be completed.
Insights
Culture-negative peritonitis in continuous ambulatory peritoneal dialysis (CAPD) can stem from unusual pathogens. This case highlights Mycobacterium avium complex peritonitis in an HIV-negative patient, leading to technique failure.
Area of Science:
- Nephrology
- Infectious Diseases
- Microbiology
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a common renal replacement therapy.
- Peritonitis is a significant complication of CAPD, often caused by gram-positive bacteria.
- Culture-negative peritonitis presents a diagnostic challenge, potentially involving atypical organisms.
Observation:
- A case of peritonitis in an HIV-negative patient undergoing CAPD is presented.
- The patient developed culture-negative peritonitis.
- Mycobacterium avium complex was identified as the causative agent.
Findings:
- Mycobacterium avium complex (MAC) peritonitis occurred in an immunocompetent CAPD patient.
- The infection led to technique failure.
- Treatment was not completed due to patient's death from unrelated causes.
Implications:
- This case underscores the importance of considering atypical organisms, such as mycobacteria, in culture-negative CAPD peritonitis, even in HIV-negative individuals.
- Early diagnosis and appropriate treatment are crucial for managing MAC peritonitis in CAPD patients.
- Further research into diagnostic and therapeutic strategies for culture-negative peritonitis in CAPD is warranted.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Peritoneal Dialysis I: Introduction and Procedure
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Hemodialysis II: Procedure and Complications
Hemodialysis I: Introduction
